CHMP positive recommendation for Eliquis (apixaban) to treat venous thromboembolism (VTE) and prevention of recurrent VTE in children – BMS + Pfizer
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Eliquis… read more.
